GRAS-compliant parabiotic biomasses enriched with functional proteins and lipids
Provides GRAS-compliant parabiotic biomasses enriched with functional peptides, fatty acids, phospholipids, and postbiotics. Derived from probiotics and marine bacteria, the ingredients are positioned to support health applications such as muscle gain, obesity prevention, and improved heart health. Produced using precision fermentation and synthetic biology platforms and designed for incorporation into foods and beverages, with scalable manufacturing capacity and multiple TRL6 ingredients.
Overview
A solution offering GRAS-compliant parabiotic biomasses derived from probiotics and marine bacteria. The biomasses are enriched with functional peptides, fatty acids, phospholipids, and postbiotics, with targeted health benefits including muscle gain, obesity prevention, and improved heart health. Using precision fermentation and synthetic biology platforms, these ingredients are intended to be adaptable to a range of food and beverage applications to support demand for novel, health-boosting proteins and peptides.
Technical specifications
- GRAS-compliant biomasses: Derived from probiotics and marine bacteria, enriched with functional compounds
- Key ingredients: Peptides, fatty acids, phospholipids, postbiotics
- Applications: Adaptable to foods and beverages, with health benefits such as muscle gain and heart health
- Production scale: CDMO capacity of 25,000L per tank to support scalable production
- Current development: Two TRL6 ingredients with milky taste and texture
Technology readiness level
Currently at Technology Readiness Level 6, these biomasses have undergone significant validation, including animal trials demonstrating efficacy in muscle gain and obesity prevention. Future steps include co-development with industry partners to optimize product formulations, conduct in vivo health benefit validation, and achieve regulatory clearance for commercial readiness by 2026.
About BiomeMega Biosciences (Singapore)
BiomeMega Biosciences is a biotechnology company focused on research, development, and supply of probiotic-derived ingredients, specializing in the bio-enhancement and application of Omega 3, 6, 7, and 9 fatty acids. The company utilizes a proprietary platform centered on precision fermentation to isolate and scale bacterial and fungal species capable of producing fatty acids, short-chain fatty acids, and antioxidants. By leveraging genetic constructs and next-generation probiotic-derived ingredients, BiomeMega aims to provide sustainable, non-GMO solutions for the nutraceutical, food, and pharmaceutical industries, including the development of functional peptides and post-biotic membranes.
These innovations are designed to address chronic health issues by potentially serving as therapeutic agents or as models for improving chemical synthesis. Through collaborations with universities and industry partners, BiomeMega aims to transform human health by improving cell function and preventing diseases associated with modern lifestyles. The company’s research pipeline, supported by preclinical trials demonstrating benefits such as lean muscle growth and metabolic health, positions its probiotic membrane technology for applications in health products, cosmetics, and cardiovascular medicine.
Inquire about this partnering listing
Industry applications
delivered to your inbox.